Results 181 to 190 of about 23,985 (238)

Oncolytic virus OVV-03 enhances CAR-T cell therapy against glioblastoma via immune modulation and specific HER2 upregulation. [PDF]

open access: yesOncoimmunology
Tang Y   +18 more
europepmc   +1 more source

Engineered oncolytic virus armed with anti-PCSK9 scFv boosts long-term CD8<sup>+</sup> T cell immunity via rewiring MHC-I antigen presentation. [PDF]

open access: yesCell Rep Med
Feng H   +13 more
europepmc   +1 more source

Oncolytic virus M1 reinvigorates CD8<sup>+</sup> T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen. [PDF]

open access: yesCell Mol Immunol
Han Y   +25 more
europepmc   +1 more source

IP6K2 mutations as a novel mechanism of resistance to oncolytic virus therapy. [PDF]

open access: yesJ Transl Med
Huang Z   +9 more
europepmc   +1 more source

Neural stem cell-delivered oncolytic virus via intracerebroventricular administration enhances glioblastoma therapy and immune modulation. [PDF]

open access: yesJ Immunother Cancer
Chai H   +13 more
europepmc   +1 more source

Identifying gene expression signatures of oncolytic virus response in patient-derived pancreatic ductal adenocarcinoma organoids. [PDF]

open access: yesMol Ther Oncol
Huberts M   +6 more
europepmc   +1 more source

Virus, Oncolytic Virus and Human Prostate Cancer [PDF]

open access: yesCurrent Cancer Drug Targets, 2017
Prostate cancer (PCa), a disease, is characterized by abnormal cell growth in the prostate - a gland in the male reproductive system. Although older age and a family history of the disease have been recognized as the risk factors of PCa, the cause of this cancer remains unclear.
Liu, Guang Bin   +3 more
openaire   +6 more sources

Enantiomeric Virus-Inspired Oncolytic Particles for Efficient Antitumor Immunotherapy [PDF]

open access: yesACS Nano, 2023
Synthesizing biomimetic systems with stereospecific architectures and advanced bioactivity remains an enormous challenge in modern science. To fundamentally eliminate biosafety issues of natural oncolytic viruses, the development of synthetic virus ...
Xianghui Xu, Yachao Li, Zenan Zeng
exaly   +2 more sources

Home - About - Disclaimer - Privacy